48
Participants
Start Date
August 3, 2021
Primary Completion Date
January 16, 2023
Study Completion Date
May 9, 2023
S95011 concentrate for solution for infusion
IV administration every 2 weeks until week 4 and then every 3 weeks until week 10.
Placebo concentrate for solution for infusion
IV administration every 2 weeks until week 4 and then every 3 weeks until week 10.
Debreceni Egyetem Orvos és Egészségtudományi Centrum Belgyógyászat C épület - Klinikai Immunológiai Tanszék, Debrecen
The Queen Elizabeth Hospital Rheumatology Unit, Woodville
Békés Megyei Központi Kórház, Pándy Kálmán Tagkórház, Infektológia-Hepatológia, Gyula
Vita Verum Medical Bt. Berényi u. 72-100. 95. számú épület 16. Rendelő, Székesfehérvár
CLINICAL GAIAS SANTIAGO Servicio de Reumatología, Santiago de Compostela
Altoona Center for Clinical Research, Duncansville
Hôpital Saint-André, Bordeaux
Hospital Infanta Luisa Quirón Salud Servicio de Reumatología, Seville
Hôpital Laribiosière, Paris
Hôpital Pitié-Salpêtrière, Paris
Hôpital Saint Antoine, Paris
Universitätsklinikum Freiburg Department Innere Medizin Klinik für Rheumatologie und Klinische Immunologie, Freiburg im Breisgau
Colorado Arthritis Associates, Lakewood
Universitätsklinikum Erlangen Medizinische Klinik 3 Rheumatologie und Immunologie, Erlangen
CHU de Bicêtre, Le Kremlin-Bicêtre
CLINICA SAGRADA FAMILIA Servicio de Reumatología y Unidad de Ensayos Clínicos, Barcelona
Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham
Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Southampton General Hospital, University Hospital Southampton NHS Trust, Southampton
ADIR, a Servier Group company
INDUSTRY
Institut de Recherches Internationales Servier
OTHER